Compare GIS & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GIS | IQV |
|---|---|---|
| Founded | 1866 | 1982 |
| Country | United States | United States |
| Employees | N/A | 93000 |
| Industry | Packaged Foods | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.8B | 27.9B |
| IPO Year | 2003 | 2013 |
| Metric | GIS | IQV |
|---|---|---|
| Price | $37.43 | $172.84 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 16 | 16 |
| Target Price | $42.75 | ★ $230.56 |
| AVG Volume (30 Days) | ★ 9.2M | 1.3M |
| Earning Date | 03-18-2026 | 05-05-2026 |
| Dividend Yield | ★ 6.52% | N/A |
| EPS Growth | N/A | ★ 4.67 |
| EPS | 3.56 | ★ 7.84 |
| Revenue | $2,037,800,000.00 | ★ $9,739,000,000.00 |
| Revenue This Year | N/A | $6.77 |
| Revenue Next Year | N/A | $5.87 |
| P/E Ratio | ★ $10.52 | $22.10 |
| Revenue Growth | 4.11 | ★ 41.60 |
| 52 Week Low | $35.64 | $134.65 |
| 52 Week High | $60.15 | $247.05 |
| Indicator | GIS | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 31.95 | 51.09 |
| Support Level | $35.64 | $157.59 |
| Resistance Level | $51.06 | $193.26 |
| Average True Range (ATR) | 0.90 | 5.86 |
| MACD | 0.17 | 1.89 |
| Stochastic Oscillator | 41.61 | 73.85 |
General Mills is a global packaged-food company that produces snacks, cereal, convenient meals, dough, baking mixes and ingredients, pet food, and superpremium ice cream. Its largest brands are Nature Valley, Cheerios, Old El Paso, Pillsbury, Betty Crocker, Blue Buffalo, and Haagen-Dazs. In fiscal 2025, 81% of its revenue was derived from the United States, although the company also operates in Canada, Europe, Australia, Asia, and Latin America. Although most of General Mills' products are sold through retail stores to consumers, the company also sells products to the foodservice channel and the commercial baking industry.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.